Moleculin Biotech, Inc.

MBRX· Nasdaq

Since Oct 5, 2025

Transactions: 3
Purchases: 3
Sales: 0
Purchase value: $0.00
Sale value: $0.00

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Foster Jonathan P.Chief Financial Officer

Filed Aug 5, 2026Period of report Aug 3, 20260001437749-26-025929

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
PurchaseAug 3, 2026	Common Stock^F1	293,333	—	—	305,673	Direct

Filing footnotes · 1

F1On August 3, 2026, the reporting person acquired 293,333 shares of common stock and Series I warrants to purchase 879,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering.

Open on SEC EDGAR

Klemp Walter VDirector · CEO and President

Filed Aug 5, 2026Period of report Aug 3, 20260001437749-26-025928

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
PurchaseAug 3, 2026	Common Stock^F1	533,333	—	—	564,340	Direct

Picker Donald HChief Science Officer

Filed Aug 5, 2026Period of report Aug 3, 20260001437749-26-025927

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
PurchaseAug 3, 2026	Common Stock^F1	173,333	—	—	174,086	Direct

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.